share_log

Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings

Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings

醫療保健板塊似乎拖累了UnitedHealth的正面收益
Benzinga Real-time News ·  2021/10/15 22:46

Stock futures were pointing to a higher open even before Goldman Sachs (NYSE:GS) reported better than expected earnings. Goldman rose 2.25% before the open helping to lead another group of financial stocks that have kicked off a strong earnings season. PNC Financial (NYSE:PNC) and Truist Financial Corp (NYSE:TFC) were among the group of financial stocks that also beat on earnings and revenue estimates. Financials continue to benefit from the rise in yields, but supply chain and inflation problems are likely to be factors as other market sectors begin to report next week.

股指期貨甚至在此之前就指向更高的開盤價高盛(紐約證券交易所代碼:GS)公佈的收益好於預期。高盛在開盤前上漲了2.25%,幫助領漲了另一批金融股,這些股票拉開了強勁財報季的序幕。PNC金融(紐約證券交易所代碼:PNC)和TRUIST FINANCIAL CORPORATION(紐約證券交易所股票代碼:TFC)是盈利和營收預期也超過預期的金融股之一。金融股繼續受益於收益率上升,但隨着其他市場板塊下週開始公佈財報,供應鏈和通脹問題可能成為影響因素。

The Real Estate Select Sector Index ($IXRE) has been able to keep up with the S&P 500 (SPX) despite rising interest rates. On Friday morning, Prologis (NYSE:PLD) reported better-than-expected earnings and revenue leading to a premarket rally of 1.86%. The company saw a record increase in rents and a rise in occupancy.

這個房地產精選行業指數($IXRE)能夠跟上標準普爾500指數(SPX)儘管利率上升。週五早上,開場白(紐約證券交易所代碼:PLD)公佈的收益和收入好於預期,導致盤前上漲1.86%。該公司的租金創歷史新高,入住率也有所上升。

Trucking company JB Hunt (NASDAQ:JBHT) was 2.8% higher in premarket trading after announcing that it beat estimates on earnings and revenue. The company has benefited from high demand as trucking is a central piece of the supply chain. JB Hunt reported growth in all business segments which helped to offset rising wages and the cost of new trucks. A strong transportation sector is often a good sign for the economy because it’s an indicator of demand.

卡車運輸公司JB Hunt納斯達克股票代碼:JBHT)在盤前交易中上漲2.8%,此前該公司宣佈收益和收入超出預期。由於卡車運輸是供應鏈的核心部分,該公司受益於高需求。JB Hunt報告稱,所有業務部門都出現了增長,這有助於抵消工資上漲和新卡車成本上漲的影響。強勁的運輸業通常是經濟的好兆頭,因為它是需求的指標。

A couple of stocks are down in premarket trading. Corsair Gaming (NASDAQ:CRSR) fell 5.5% before the open after reducing its third-quarter revenue guidance. The company cited supply chain issues for the lower outlook. Virgin Galactic (NYSE:SPCE) fell 18% because the company had to delay the launch of its commercial space tourism business until next year.

有幾隻股票在盤前交易中下跌。海盜船遊戲納斯達克股票代碼:CRSR)開盤前下跌5.5%,此前該公司下調了第三季度營收指引。該公司將較低的前景歸咎於供應鏈問題。維珍銀河(紐約證券交易所代碼:SPCE)股價下跌18%,因為該公司不得不將其商業太空旅遊業務的推出推遲到明年。

In economic news, the Census Bureau released the monthly U.S. Retail Sales numbers for September on Friday morning which came in much higher than expected. However, the numbers are being driven in part by higher inflation. Stock futures were unchanged immediately after the news.   

在經濟新聞方面,美國人口普查局週五上午公佈了美國9月份的月度零售銷售數據,遠遠高於預期。然而,這些數字在一定程度上是由更高的通脹推動的。消息傳出後,股指期貨立即保持不變。

Sector Wellness

行業健康狀況

UnitedHealth Group (NYSE:UNH) climbed more than 4% on Thursday after announcing better-than-expected earnings, but the stock struggled to break a resistance level near $425. UNH has been testing this level since May but has been turned back by sellers. The positive announcement could help the stock eventually break resistance, but weakness in the sector could be a drag on the company.

聯合健康集團紐約證券交易所(NYSE:UNH)週四公佈好於預期的盈利後,股價攀升逾4%,但該股難以突破425美元附近的阻力位。自5月以來,UNH一直在測試這一水平,但遭到賣家的拒絕。這一利好的聲明可能有助於該股最終突破阻力,但該板塊的疲軟可能拖累該公司。

One problem with the Health Care sector is that COVID-19 and staff shortages are making elective procedures and regular health care more difficult. Last month, The New York Times reported that some hospitals were postponing surgeries for hernias, hip replacements, cancer, and heart surgeries because of the lack of beds. Recently, the Washington Post reported that coronavirus cases are falling, which could allow for more elective procedures.

醫療保健部門的一個問題是,新冠肺炎和人員短缺正在使選擇性程序和常規醫療變得更加困難。上個月,《紐約時報》報道稱,由於牀位不足,一些醫院推遲了疝氣、髖關節置換、癌症和心臟手術。最近,華盛頓郵報報道稱,冠狀病毒病例正在下降,這可能會允許進行更多的選擇性程序。

Despite the falling cases, many news agencies including Newsweek and BBC are reporting hospital staffing shortages, which means that even if rooms and beds are open, there may not be enough staff to help with treatments. Despite these shortages, medical staffing companies’ stock prices have been falling. AMN Healthcare (NYSE:AMN) has fallen more than 17% in the last two days, while Cross Country Healthcare (NASDAQ:CCRN) and Heidrick & Struggles (NASDAQ:HSII) are both down 15% and 6% respectively from their 52-week highs set just four days ago. Yet, there’s no news on what could be driving the sell-off.

儘管案件不斷下降,但包括新聞週刊英國廣播公司據報道,醫院人員短缺,這意味着即使房間和牀位開放,也可能沒有足夠的工作人員來幫助治療。儘管出現了這些短缺,但醫療人力公司的股價一直在下跌。AMN Healthcare(紐約證券交易所代碼:AMN)在過去兩天下跌超過17%,而越野醫療(納斯達克股票代碼:CCRN)和Heidrick&Struggles納斯達克股票代碼:HSII)均較四天前創下的52周高點分別下跌15%和6%。然而,目前還沒有關於可能是什麼推動了拋售的消息。

The high degree of uncertainty around health care could make it difficult for investors to diagnosis where the sector may be going.  

圍繞醫療保健的高度不確定性可能使投資者難以診斷該行業可能走向何方。

CHART OF THE DAY: FLATLINING. UnitedHealth (UNH—pink) rallied on its earnings announcement but failed to sustain a break above resistance. One negative factor is the weakness in the S&P Health Care Select Sector Index ($IXV—candlesticks). Health Care is underperforming the S&P 500 (SPX—blue) in both comparative performance and relative strength (green line).

當日圖表:壓平了。UnitedHealth(UNH-PINK)在公佈財報後上漲,但未能維持突破阻力位。一個負面因素是標準普爾醫療保健精選板塊指數(IXV-燭台)的疲軟。Health Care在相對錶現和相對實力(綠線)方面都落後於標準普爾500指數(SPX-Blue)。

Data Sources: ICE, S&P Dow Jones Indices. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.

數據來源:ICE,標普道瓊斯指數圖表來源:Thinkkorswm®平台。僅供説明之用。過去的表現並不能保證未來的結果。

Booster Shots: On the positive side of health care, vaccine maker Moderna (NASDAQ:MRNA) received a unanimous recommendation from the FDA advisory committee for its COVID-19 booster shot. The shot is recommended for patients older than 65 or at high risk. The news was a “shot in the arm” for Moderna, which was hit hard when Merck & Co Inc. (NYSE:MRK) released its testing results for its COVID-19 booster. The stock rallied more than 3% on the news but is still down 30% from its August high. Despite its recent struggles, Moderna is up more than 2000% in the last two years.

助推器注射:從醫療保健的積極一面來看,疫苗製造商現代派(納斯達克股票代碼:mRNA)收到了美國食品和藥物管理局顧問委員會對其新冠肺炎強化注射的一致推薦。建議65歲以上或高危患者注射該疫苗。這一消息對摩德納來説是一劑“強心針”,當時該公司受到了沉重的打擊。默沙東。紐約證券交易所代碼:MRK)公佈了其新冠肺炎助推器的測試結果。消息傳出後,該股上漲逾3%,但仍較8月高點下跌30%。儘管最近舉步維艱,但摩登那在過去兩年裏上漲了2000%以上。

An FDA panel is expected to meet and discuss a booster shot for the Johnson & Johnson (NYSE:JNJ) vaccine today.

美國食品和藥物管理局的一個小組預計將開會討論強生(紐約證券交易所股票代碼:JNJ)今天開始接種疫苗。

Symbiotic Relationships: Moderna was struggling to stay in business before its COVID-19 vaccine. Now, the stock is part of the S&P 500. The success with its vaccine should give the company the capital it needs to potentially get more of its drugs to market.

共生關係:在推出新冠肺炎疫苗之前,現代汽車正艱難地維持着業務。現在,這隻股票是標準普爾500指數的一部分。疫苗的成功應該會給該公司帶來所需的資金,使其有可能將更多的藥物推向市場。

Biotech stocks have also been weak despite being a favorite among aggressive growth investors. The Nasdaq Biotech Index (NBI) is trading near where it started the year. Unfortunately, new science and early-stage success doesn’t guarantee FDA approval. Additionally, a small portfolio of drugs provides a lot of risk for biotech companies, or they depend heavily on partnerships with other drug companies. For example, Seagen (NASDAQ:SGEN) creates antibody-drug conjugates used in monoclonal antibodies. The company has three drugs Adcetris, Padcev, and Tukysa. However, Adcetris accounts for the majority of sales that come from a partnership with Takeda Pharmaceuticals (NYSE:TAK) and licensing revenue from Merck.

生物科技股也一直疲軟,儘管它是激進的成長型投資者的最愛。這個納斯達克生物技術指數(NBI)目前的交易價格接近今年年初的水平。不幸的是,新的科學和早期的成功並不能保證FDA的批准。此外,少量的藥物組合給生物技術公司帶來了很大的風險,或者他們嚴重依賴於與其他製藥公司的合作伙伴關係。例如,SeaGen(納斯達克市場代碼:SGEN)製造用於單克隆抗體的抗體-藥物結合物。該公司有三種藥物Adcetris,Padcev和Tukysa。然而,Adcetris的大部分銷售額來自與武田製藥(紐約證券交易所股票代碼:TAK)和默克公司的許可收入。

In a Heartbeat: Despite the weakness in much of the Health Care sector, there appears to be some life in medical device companies. The Dow Jones U.S. Medical Equipment Index ($DJUSAM) bounced off support around the 2830 level on Thursday. The bounce appears to be driven by companies like Stryker Corporation (NYSE:SYK), Becton Dickson (NYSE:BDX), and Medtronic (NYSE:MDT), all of which experienced similar bounces. While there’s little news around the industry group, it’s exhibiting greater relative strength than other industries in the sector.

在一個心跳聲中:儘管醫療保健行業的大部分行業表現疲軟,但醫療器械公司似乎有了一些生機。這個道瓊斯美國醫療設備指數($DJUSAM)週四從2,830水準附近的支撐位反彈。這種反彈似乎是由像這樣的公司推動的史泰克公司(紐約證券交易所代碼:SYK),貝頓·迪克森(紐約證券交易所代碼:BDX),以及美敦力(紐約證券交易所股票代碼:MDT),所有股票都經歷了類似的反彈。雖然關於這個行業集團的消息很少,但它比該行業的其他行業表現出了更大的相對實力。

TD Ameritrade® commentary for educational purposes only. Member SIPC.

TD ameritrade®評論僅用於教育目的。成員SIPC。

Image Sourced from Pixabay

圖片來源:Pixabay

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論